Viktor Minenko
Research Subjects
Viktor Minenko has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr V. Rozhko
Republican Research Center for Radiation Medicine and Human Ecology
3 shared publications - Alina V. Brenner
Department of Epidemiology, Radiation Effects Research Foundation
3 shared publications - Elizabeth Khaykin Cahoon
National Cancer Institute 1 Bethesda, Md
3 shared publications - Iryna A. Vasiukhina
Republican Research Center for Radiation Medicine and Human Ecology 3 Homyel
3 shared publications - Kiyohiko Mabuchi
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA
3 shared publications - Lydia B. Zablotska
Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, San Francisco, USA
3 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by American Association for Cancer Research (AACR)
Data from Radiation Risk of Screening-Detected Diffuse Goiter in a Belarusian Cohort Exposed as Children or Adolescents to Iodine-131 after Chernobyl
Background:We previously reported a significantly increased risk of thyroid cancer due to radioactive iodine-131 after the 1986 Chernobyl nuclear accident in a cohort of children and adolescents from Belarus. Radiation-related cancer risks were five times higher among those with diffuse goiter; however, the relationship between radiation dose and diffuse goiter is not well understood. Methods:We used logistic regression to analyze data from 10,278 study participants [mean thyroid dose = 0.63 gray (Gy)] who were screened 10 to 15 years after exposure according to a standardized protocol, which specified thyroid size assessment by both ultrasound and palpation. Results:Diffuse goiter was identified in 1,811 subjects and was significantly associated with 131I dose (P < 0.001). The linear model provided the best fit to the data at doses <0.5 Gy [odds ratio (OR) at 1 Gy = 2.45; 95% confidence interval, 1.70–3.41] and linear–exponential model at doses <1.5 Gy (OR at 1 Gy = 1.84). Age at exposure and indicators of iodine deficiency both before the accident (place of residence) and during screening (urinary iodine levels) significantly modified the dose-response (all P values < 0.01). Conclusions:The first systematic evaluation of radiation risks of diffuse goiter after environmental exposure found a strong, statistically significant association with thyroid dose. Impact:Our study shows that radiation exposure is associated with a significantly increased risk of developing diffuse goiter. Future epidemiologic studies of iodine-deficient irradiated populations should assess thyroid size.
- 1 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Radiation Risk of Screening-Detected Diffuse Goiter in a Belarusian Cohort Exposed as Children or Adolescents to Iodine-131 after Chernobyl
Background:We previously reported a significantly increased risk of thyroid cancer due to radioactive iodine-131 after the 1986 Chernobyl nuclear accident in a cohort of children and adolescents from Belarus. Radiation-related cancer risks were five times higher among those with diffuse goiter; however, the relationship between radiation dose and diffuse goiter is not well understood. Methods:We used logistic regression to analyze data from 10,278 study participants [mean thyroid dose = 0.63 gray (Gy)] who were screened 10 to 15 years after exposure according to a standardized protocol, which specified thyroid size assessment by both ultrasound and palpation. Results:Diffuse goiter was identified in 1,811 subjects and was significantly associated with 131I dose (P < 0.001). The linear model provided the best fit to the data at doses <0.5 Gy [odds ratio (OR) at 1 Gy = 2.45; 95% confidence interval, 1.70–3.41] and linear–exponential model at doses <1.5 Gy (OR at 1 Gy = 1.84). Age at exposure and indicators of iodine deficiency both before the accident (place of residence) and during screening (urinary iodine levels) significantly modified the dose-response (all P values < 0.01). Conclusions:The first systematic evaluation of radiation risks of diffuse goiter after environmental exposure found a strong, statistically significant association with thyroid dose. Impact:Our study shows that radiation exposure is associated with a significantly increased risk of developing diffuse goiter. Future epidemiologic studies of iodine-deficient irradiated populations should assess thyroid size.
- Open Access
- 1 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data Table S1 from Radiation Risk of Screening-Detected Diffuse Goiter in a Belarusian Cohort Exposed as Children or Adolescents to Iodine-131 after Chernobyl
Supplementary Data Table S1. Comparison of best-fitting dose–response models for prevalent diffuse goiter, showing odds ratios at 1 Gy, model fit statistics, and adjustments for key covariates, Belarus, 1996 to 2004.
- 1 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data Table S1 from Radiation Risk of Screening-Detected Diffuse Goiter in a Belarusian Cohort Exposed as Children or Adolescents to Iodine-131 after Chernobyl
Supplementary Data Table S1. Comparison of best-fitting dose–response models for prevalent diffuse goiter, showing odds ratios at 1 Gy, model fit statistics, and adjustments for key covariates, Belarus, 1996 to 2004.
- 16 June 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (9) , 1545-1554
Radiation risk of screening-detected diffuse goiter in a Belarusian cohort exposed as children or adolescents to iodine-131 after Chernobyl
Background: We previously reported a significantly increased risk of thyroid cancer due to radioactive iodine-131 (131I) after the 1986 Chernobyl nuclear accident in a cohort of children and adolescents from Belarus. Radiation-related cancer risks were five times higher among those with diffuse goiter, but the relationship between radiation dose and diffuse goiter is not well understood. Methods: We used logistic regression to analyze data from 10,278 study participants (mean thyroid dose=0.63 gray (Gy)) who were screened 10-15 years after exposure according to a standardized protocol, which specified thyroid size assessment by both ultrasound and palpation. Results: Diffuse goiter was identified in 1,811 subjects and was significantly associated with 131I dose (P<0.001). The linear model provided the best fit to the data at doses <0.5 Gy (excess odds ratio per gray (EOR/Gy) = 1.45, 95% confidence interval (CI): 0.70, 2.41) and linear-exponential model at doses <1.5 Gy (odds ratio (OR) at 1 Gy = 1.84). Age at exposure and indicators of iodine deficiency both before the accident (place of residence) and during screening (urinary iodine levels) significantly modified the dose-response (all P-values < 0.01). Conclusions: The first systematic evaluation of radiation risks of diffuse goiter after environmental exposure found a strong, statistically significant association with thyroid dose. Impact: Our study shows that radiation exposure is associated with a significantly increased risk of developing diffuse goiter. Future epidemiological studies of iodine-deficient irradiated populations should assess thyroid size.
- 16 June 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (9) , 1545-1554
Radiation risk of screening-detected diffuse goiter in a Belarusian cohort exposed as children or adolescents to iodine-131 after Chernobyl
Background: We previously reported a significantly increased risk of thyroid cancer due to radioactive iodine-131 (131I) after the 1986 Chernobyl nuclear accident in a cohort of children and adolescents from Belarus. Radiation-related cancer risks were five times higher among those with diffuse goiter, but the relationship between radiation dose and diffuse goiter is not well understood. Methods: We used logistic regression to analyze data from 10,278 study participants (mean thyroid dose=0.63 gray (Gy)) who were screened 10-15 years after exposure according to a standardized protocol, which specified thyroid size assessment by both ultrasound and palpation. Results: Diffuse goiter was identified in 1,811 subjects and was significantly associated with 131I dose (P<0.001). The linear model provided the best fit to the data at doses <0.5 Gy (excess odds ratio per gray (EOR/Gy) = 1.45, 95% confidence interval (CI): 0.70, 2.41) and linear-exponential model at doses <1.5 Gy (odds ratio (OR) at 1 Gy = 1.84). Age at exposure and indicators of iodine deficiency both before the accident (place of residence) and during screening (urinary iodine levels) significantly modified the dose-response (all P-values < 0.01). Conclusions: The first systematic evaluation of radiation risks of diffuse goiter after environmental exposure found a strong, statistically significant association with thyroid dose. Impact: Our study shows that radiation exposure is associated with a significantly increased risk of developing diffuse goiter. Future epidemiological studies of iodine-deficient irradiated populations should assess thyroid size.